News
19h
Zacks.com on MSNWhy Johnson & Johnson (JNJ) is a Top Dividend Stock for Your PortfolioDividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes? Let's find out.
NDA for icotrokinra for the treatment of adults and adolescents 12 years of age and older with moderate to severe plaque ...
Yet, within the past 24 hours, Trump has doubled the tariffs on India to 50%, imposed an additional 15% on Japan, announced a ...
Yacktman Asset Management's Q2 2025 13F portfolio value dipped slightly to $7.44B. Click here to read more about the ...
19h
Zacks.com on MSNHALO Stock Up on Q2 Earnings and Revenue Beat, Raised 2025 ViewHalozyme jumps 5.3% on second-quarter earnings and revenue beat, fueled by strong royalty growth, and a raised 2025 outlook.
21h
Zacks.com on MSNBayer Beats on Q2 Earnings and Sales, Raises '25 Adjusted Sales ViewBayer AG (BAYRY) reported second-quarter 2025 core earnings of 35 cents per American Depositary Receipt (ADR), which ...
15hon MSN
Luke Lango’s interview on Physical AI… another warning about AI and your job… watch out for tariffs on semiconductors… balancing the tension… the latest on tariffs VIEW IN BROWSER Over the past two ...
Woes for U.S. healthcare stocks have worsened this year driven partly by Trump administration policies, although some ...
New, higher and changing tariffs will ripple through the economy and into share prices for many quarters to come.
Discover how advances in device technology and regional demand shifts are reshaping the future of medical aesthetics in BCC Research’s latest market analysis.”Boston, Aug. 06, 2025 (GLOBE NEWSWIRE) -- ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results